Form 4: Select Medical CEO Mullin Files Form 4 Post-Merger

Thomas P. Mullin, CEO of Select Medical Corporation, has filed a Form 4 detailing the disposition of securities in connection with the company's merger.

Summary

• This filing is a Form 4, which reports changes in the beneficial ownership of securities by company insiders.
• Thomas P. Mullin, Chief Executive Officer of Select Medical Corporation, reported a transaction on June 30, 2026.
• The transaction involved the disposition of 391,709 shares of Common Stock.
• This disposition occurred under the Agreement and Plan of Merger entered into on March 2, 2026.
• Prior to the merger's effective time, Mullin contributed 175,042 common shares and 216,667 restricted shares to Parent (Stallion Intermediate Corporation).
• In exchange, he received an equivalent amount of common stock and restricted shares of Parent.
• These Parent shares were subsequently exchanged for interests in Stallion Group Parent, LP.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard post-merger transaction by an executive and does not indicate new financial performance or strategic shifts.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for insiders following significant corporate events like mergers, providing transparency on ownership changes.

Stakeholder Impact

• Shareholders: The filing provides transparency on the CEO's post-merger shareholdings, which is standard practice and expected following a merger.

Key Dates

Keywords

Form 4, SEC Filing, Select Medical Corporation, Thomas P. Mullin, Merger, Beneficial Ownership, Securities Disposition